R. Billingham/L. Brent/P. Medawar: Actively acquired tolerance for foreign 
cells. Nature 172 (1953), 603-606.

Mark Davis/Joel Buxbaum (ed.): T-cell receptor use in human autoimmune
disease. Ann. NY Ac. Sci. 756 (1995), 460p. 0-89766-915-0. $175.

6665 George Eisenbarth/Donald Bellgrau: Autoimmunity.
Science & Medicine May/June 1994, 38-47.

C. Goodnow/S. Adelstein/A. Basten: The need for central and peripheral 
tolerance in the B cell repertoire. Science 248 (1990), 1373-1379.

7309 Thomas Griffith a.o.: Fas ligand-induced apoptosis as a mechanism
of immune privilege. Science 17 November 1995, 1189-1992.
The eye is a privileged site that cannot tolerate destructive 
inflammatory responses.

J. Kappler/N. Roehm/Philippa Marrack: T cell tolerance by clonal elimination 
in the thymus. Cell 49 (1987), 273-280.

5369 Philippa Marrack/John Kappler: How the immune system recognizes the body.
Scientific American September 1993, 48-55.

9257 Henry McFarland: Complexities in the treatment of autoimmune disease.
Science 20 December 1996, 2037-2038.

N. Mitchison: A walk round the edges of self tolerance. 
Annals of Rheumatic Diseases 52 (1993), S 3-5 (supplement).

Gerald Nepom/Henry Erlich: MHC class-II molecules and autoimmunity.
Annual Review of Immunology 9 (1991), 493-525.

P. Ohashi a.o.: Ablation of tolerance and induction of diabetes by virus 
infection in viral antigen transgenic mice. Cell 645 (1991), 305-317.

M. Oldstone: Molecular mimicry and autoimmune disease.
Cell 50 (1987), 819-820.

Noel Rose/Ian Mackay: The autoimmune diseases. Academic Press 1992.

Ronald Schwartz: A cell culture model for T lymphocyte clonal anergy.
Science 248 (1990), 1349-1356.

6406 Ronald Schwartz: Anergie von T-Zellen.
Spektrum 1993/10, 76-83. Erkennen Immunzellen Antigene in Abwesenheit der 
richtigen Hilfssignale, gehen sie in einen inaktiven, als Anergie bezeichneten
Zustand ueber, der moeglicherweise auch dazu dient, das Immunsystem tolerant 
gegenueber koerpereigenen Molekuelen zu machen.

5373 Lawrence Steinmann: Autoimmune defense.
Scientific American September 1993, 74-83.
Misguided assaults on the self produce multiple sclerosis, juvenile diabetes 
and other chronic illnesses. Promising therapies are emerging.
Autoimmune diseases may involve any organ system, although some are affected 
more commonly than others: The white matter of the brain and spinal cord in 
multiple sclerosis, the lining of joints in rheumatoid arthritits, the 
insulin-secreting cells in juvenile diabetes mellitus. Other forms of 
autoimmune disease ravage the connections between nerve and muscle in 
myasthenia gravis, stimulate the thyroid gland to produce excessive amounts 
of thyroid hormone in Graves' disease, blister the skin in pemphigus vulgaris 
or destroy the kidneys and other organs in a condition called systemic lupus 
erythematosus.

Lawrence Steinmann: The development of rational strategies for selective 
immunotherapy against autoimmune demyelinating disease.
Advances in Immunology 49 (1991), 357-379.

7308 J. Wayne Streilein: Unraveling immune privilege.
Science 17 November 1995, 1158-1159.
Immune privilege protects tissue grafted to certain sites (the eye, testis,
brain) from rejection.

David Wraith/Hugh McDevitt/Lawrence Steinmann/Hans Acha-Orbea: T cell 
recognition as the target for immune intervention in autoimmune disease.
Cell 57 (1989), 709-715.